News

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year ...
Resmed Names Salli Schwartz as Chief Investor Relations Officer
Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment communitySAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: ...
ResMed shares jump 8% on strong Q3 update
ResMed Inc. (ASX: RMD) shares are having a strong finish to the week. Here's why investors are buying this blue chip ...
A Look Ahead: ResMed's Earnings Forecast
Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...
ASX rises, US-China trade deal in focus; exec reshuffle at Domino’s
Shares edge higher; Trump to reportedly wind down tariff rate on China; Tesla leaps 5pc; ResMed evades trade war blow; iron ...
Morningstar2d
Resmed Names Salli Schwartz as Chief Investor Relations Officer
In this role, Schwartz will lead Resmed's global investor relations function and report to Mick Farrell ... moment in its strategy to make better sleep and breathing health more accessible ...
Nasdaq2d
Resmed Appoints Salli Schwartz as Chief Investor Relations Officer
the global leader in health technology focused on sleep, breathing ... In this role, Schwartz will lead Resmed's global investor relations function and report to Mick Farrell, Chairman of the ...
2RMD : Assessing ResMed: Insights From 5 Financial Analysts
In the assessment of 12-month price targets, analysts unveil insights for ResMed, presenting an average target of $267.0, a ...
The Hamilton Spectator3d
Resmed Names Salli Schwartz as Chief Investor Relations Officer
SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep ... relations function and report to Mick Farrell, Chairman ...